News
-
-
-
COMMUNIQUÉ DE PRESSE
Applied DNA Announces Pricing of $6.5 Million Registered Direct Offering and Concurrent Private Placement
Applied DNA Sciences, Inc. announces the pricing of a $6.5 million registered direct offering and concurrent private placement to develop Therapeutic DNA Production Services -
-
-
COMMUNIQUÉ DE PRESSE
Applied DNA to Participate in the 2024 Maxim Healthcare Virtual Summit on Wednesday, October 16
Applied DNA Sciences to participate in Maxim Healthcare Virtual Summit with CEO Dr. James A. Hayward in a fireside chat on October 16, 2024. Company overview and business focus detailed -
-
-
-